Paul E. Krumpoeck

Department Of Otolaryngology Head And Neck Surgery
Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Prevention in otology-the key to lifelong hearing health.

Prevention in otology-the key to lifelong hearing health.

Journal: HNO

Published: May 29, 2026

Multicenter Natural History Study and Long-Term Cochlear Implant Outcomes in Usher Syndrome Subtypes.

Multicenter Natural History Study and Long-Term Cochlear Implant Outcomes in Usher Syndrome Subtypes.

Journal: Ear and hearing

Published: April 23, 2026

Intermediate filaments link glutamate-aspartate transporter deficiency to cochlear synaptopathy.

Intermediate filaments link glutamate-aspartate transporter deficiency to cochlear synaptopathy.

Journal: The FEBS journal

Published: February 23, 2026

Prevention in otology-the key to lifelong hearing health

Prevention in otology-the key to lifelong hearing health

Journal: HNO

Published: November 01, 2025

Safety and feasibility of a multimodal approach for orchestra musicians with playing-related musculoskeletal disorders (PRMDs).

Safety and feasibility of a multimodal approach for orchestra musicians with playing-related musculoskeletal disorders (PRMDs).

Journal: Wiener klinische Wochenschrift

Published: March 26, 2025

Inner Ear Gene Therapy: An Overview from Bench to Bedside.

Inner Ear Gene Therapy: An Overview from Bench to Bedside.

Journal: Molecular diagnosis & therapy

Published: November 05, 2024

Prestin in Human Perilymph, Cerebrospinal Fluid, and Blood as a Biomarker for Hearing Loss.

Prestin in Human Perilymph, Cerebrospinal Fluid, and Blood as a Biomarker for Hearing Loss.

Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Published: April 08, 2024

Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.

Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.

Journal: The Prostate

Published: April 21, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026